Home › Cancro ai polmoni › Pennsylvania
Studi clinici su Cancro ai polmoni nello stato di Pennsylvania
57 studi su Cancro ai polmoni cercano partecipanti presso sedi nello stato di Pennsylvania.
Città nello stato di Pennsylvania
- Philadelphia36 studi
- Pittsburgh23 studi
- Reading11 studi
- Harrisburg9 studi
- York8 studi
- Allentown7 studi
- Scranton6 studi
- Chambersburg6 studi
- New Castle4 studi
- Erie4 studi
- Hazleton3 studi
- Williamsport3 studi
- Lancaster3 studi
Testo ufficiale dello studio (inglese)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- e altri 53
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04267848The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- e altri 2
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- e altri 7
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Bryn Mawr Hospital, Bryn Mawr
- Penn State Milton S Hershey Medical Center, Hershey
- Riddle Memorial Hospital, Media
- e altri 6
In reclutamentoFase 3
Età 70 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Bryn Mawr Hospital, Bryn Mawr
- e altri 12
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT04181060Empathic Communication Skills (ECS) Training
- University of Pennsylvania (Data Collection Only), Philadelphia
- Fox Chase Cancer Center (Data Collection Only), Philadelphia
In reclutamentoVolontari sani benvenuti
Età da 18 a 100 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT05456841Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Bryn Mawr Hospital, Bryn Mawr
- e altri 14
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06498635Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Alliance Cancer Specialists, Sellersville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06765109Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Penn State Milton S. Hershey Medical Center, Hershey
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06881784A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
- Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06312137A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Alliance Cancer Specialists - Media, Media
- Guthrie Medical Group, Sayre
In reclutamentoFase 3
Età da 18 a 100 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05920356A Registry for People With Lung Cancer
- Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
- ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06424327Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Pittsburgh
In reclutamentoFase 2
Età da 18 a 95 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT05061550Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Allegheny Health Network, Pittsburgh
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Hospital of the University of Pennsylvania, Philadelphia
- West Penn Allegheny Health, Pittsburgh
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07100080Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06287775A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- St. Luke's University Health Network, Bethlehem
- Allegheny Cancer Center, Pittsburgh
- Reading Hospital - McGlinn Cancer Institute, West Reading
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Alliance Cancer Specialists, PC, Horsham
- Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07012031AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Philadelphia
In reclutamentoFase 1/2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07038343Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Fox Chase Cancer Center, Philadelphia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07185997Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT06712355Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
- Hospital of the University of Pennsylvania, Philadelphia
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07499674Pemefolacianine for IMI of Lung Cancer
- University of Pennsylvania, Philadelphia
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT07772895A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Abramson Cancer Center ( Site 0010), Philadelphia
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT06731907Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Chambersburg Hospital, Chambersburg
- Geisinger Medical Center, Danville
- e altri 17
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05624996Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 lug 2026 · NCT06060613Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- Clinical Research Associates of Central Pennsylvania, DuBois
In reclutamento
Età da 50 a 80 · Tutti i sessi · Aggiornato il 16 lug 2026 · NCT07168993Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT07315113Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 giu 2026 · NCT06162221A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Sidney Kimmel Cancer Center, Philadelphia
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT07458347Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Allegheny General Hospital, Natrona Heights
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 26 giu 2026 · NCT04614103MOv19-BBz CAR T Cells in FRa+ Cancers
- University of Pennsylvania, Philadelphia
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 giu 2026 · NCT07116057A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- UPMC Hillman Cancer Center, Pittsburgh
In reclutamentoFase 1/2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT05361174Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- UPMC Hillman Cancer Center at Butler Health System, Butler
- e altri 37
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT05642572Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
- Penn Medicine University City, Philadelphia
- Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine Washington Square, Philadelphia
In reclutamento
Età da 35 a 89 · Tutti i sessi · Aggiornato il 2 giu 2026 · NCT05968898Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
In reclutamentoVolontari sani benvenuti
Età da 50 a 77 · Tutti i sessi · Aggiornato il 29 mag 2026 · NCT05679349Telehealth Collaborative Care Model (CoCM) in Lung Cancer
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 mag 2026 · NCT07102147Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Fox Chase Cancer Center, Philadelphia
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 mag 2026 · NCT05800587Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.